European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

Pier Luigi Zinzani, Lionel Karlin, John Radford, Dolores Caballero, Paul Fields, Martine E D Chamuleau, Francesco d'Amore, Corinne Haioun, Catherine Thieblemont, Eva González-Barca, Carlos Grande García, Peter W Johnson, Gustaaf W van Imhoff, Thomas Ng, Karen Dwyer, Franck Morschhauser

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)e407-e410
JournalHaematologica
Volume101
Issue number10
DOIs
Publication statusPublished - 2016

Cite this

Zinzani, Pier Luigi ; Karlin, Lionel ; Radford, John ; Caballero, Dolores ; Fields, Paul ; Chamuleau, Martine E D ; d'Amore, Francesco ; Haioun, Corinne ; Thieblemont, Catherine ; González-Barca, Eva ; García, Carlos Grande ; Johnson, Peter W ; van Imhoff, Gustaaf W ; Ng, Thomas ; Dwyer, Karen ; Morschhauser, Franck. / European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. In: Haematologica. 2016 ; Vol. 101, No. 10. pp. e407-e410.
@article{28d3b9b10cb54864af60039a4ef346c9,
title = "European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma",
author = "Zinzani, {Pier Luigi} and Lionel Karlin and John Radford and Dolores Caballero and Paul Fields and Chamuleau, {Martine E D} and Francesco d'Amore and Corinne Haioun and Catherine Thieblemont and Eva Gonz{\'a}lez-Barca and Garc{\'i}a, {Carlos Grande} and Johnson, {Peter W} and {van Imhoff}, {Gustaaf W} and Thomas Ng and Karen Dwyer and Franck Morschhauser",
year = "2016",
doi = "10.3324/haematol.2016.146977",
language = "English",
volume = "101",
pages = "e407--e410",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "10",

}

Zinzani, PL, Karlin, L, Radford, J, Caballero, D, Fields, P, Chamuleau, MED, d'Amore, F, Haioun, C, Thieblemont, C, González-Barca, E, García, CG, Johnson, PW, van Imhoff, GW, Ng, T, Dwyer, K & Morschhauser, F 2016, 'European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma' Haematologica, vol. 101, no. 10, pp. e407-e410. https://doi.org/10.3324/haematol.2016.146977

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma. / Zinzani, Pier Luigi; Karlin, Lionel; Radford, John; Caballero, Dolores; Fields, Paul; Chamuleau, Martine E D; d'Amore, Francesco; Haioun, Corinne; Thieblemont, Catherine; González-Barca, Eva; García, Carlos Grande; Johnson, Peter W; van Imhoff, Gustaaf W; Ng, Thomas; Dwyer, Karen; Morschhauser, Franck.

In: Haematologica, Vol. 101, No. 10, 2016, p. e407-e410.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

AU - Zinzani, Pier Luigi

AU - Karlin, Lionel

AU - Radford, John

AU - Caballero, Dolores

AU - Fields, Paul

AU - Chamuleau, Martine E D

AU - d'Amore, Francesco

AU - Haioun, Corinne

AU - Thieblemont, Catherine

AU - González-Barca, Eva

AU - García, Carlos Grande

AU - Johnson, Peter W

AU - van Imhoff, Gustaaf W

AU - Ng, Thomas

AU - Dwyer, Karen

AU - Morschhauser, Franck

PY - 2016

Y1 - 2016

U2 - 10.3324/haematol.2016.146977

DO - 10.3324/haematol.2016.146977

M3 - Article

VL - 101

SP - e407-e410

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 10

ER -